Gayatri Sugars Gets BSE Trading Approval for Preferential Shares
Gayatri Sugars Limited announced that BSE Limited has granted trading approval for 13,26,664 equity shares of face value ₹10 each, issued to non-promoters on a preferential basis following the conversion of warrants.
The said equity shares will be listed and admitted to trading with effect from January 28, 2026.
Suraj Estate Developers Ltd Reports Strong Q3 & 9MFY26 Performance
Suraj Estate Developers Ltd released its unaudited financial results for Q3 and nine months ended FY26, reporting robust operational growth driven by commercial traction and strategic land acquisitions.
Q3FY26 Operational Highlights
Sales Value: ₹253 crore, up 137% YoY
Sales Area: 51,826 sq. ft., up 211% YoY
Collections: ₹124 crore, up 48% YoY
9MFY26 Operational Performance
Sales Value: ₹487 crore, up 38% YoY
Sales Area: 1.03 lakh sq. ft., up 56% YoY, led by commercial portfolio
Collections: ₹284 crore, reflecting stable customer confidence
Q3FY26 Consolidated Financials
Total Income: ₹181.5 crore, up 6% YoY
EBITDA: ₹55.0 crore, up 15% YoY; margin at 30.3%
PAT: ₹25.2 crore, up 26% YoY; margin at 13.8%
Key Business Developments
Suraj One Business Bay Launch: Clocked ~₹200 crore sales (~40,000 sq. ft.) within 45 days
Land Acquisition: Two parcels acquired in Bandra West to strengthen land bank
Recognition: Awarded Euromoney Real Estate Award 2025 – India’s Best Residential Developer
Management reiterated its focus on South-Central Mumbai redevelopment, commercial portfolio expansion, and leveraging its expertise in tenanted property redevelopment.
Three M Paper Boards Confirms SEBI Compliance
Three M Paper Boards Limited confirmed compliance with Regulation 6(1) of SEBI LODR Regulations for the year ended December 31, 2025.
Bigshare Services Private Limited continues as the Registrar & Share Transfer Agent under Regulation 7(1).
NDTV: Rights Issue Proceeds Utilisation Reviewed
New Delhi Television Limited informed that CARE Ratings, acting as the Monitoring Agency, reviewed the utilization of Rights Issue proceeds for Q3FY26, with no deviation observed.
Total utilised: ₹370.61 crore
Strategic initiatives: ₹45.61 crore (out of ₹71 crore)
Debt repayment: ₹229 crore (fully utilised)
General corporate purposes: ₹96 crore
₹2.19 crore reallocated from issue expenses as per offer document
L&T Uploads Q3 / 9M FY26 Earnings Call Recording
Larsen & Toubro Limited confirmed that the audio recording of its Q3 & 9M FY26 earnings call held on January 28, 2026 has been uploaded on its investor website, in compliance with SEBI LODR Regulations.
Piramal Pharma Ltd Reports Weak Q3; Recovery Seen Ahead
Piramal Pharma Limited announced its Q3 and 9M FY26 results, reflecting a challenging operating environment.
Consolidated Performance
Q3FY26 Revenue: ₹2,140 crore (-3% YoY)
9MFY26 Revenue: ₹6,117 crore (-4% YoY)
Q3 EBITDA: ₹239 crore (-32% YoY); margin 11%
PAT (Q3FY26): Loss of ₹136 crore (vs ₹4 crore profit YoY)
Segment-wise Performance
CDMO:
Q3 revenue down 9% YoY to ₹1,166 crore
Impacted by customer destocking, regulatory delays, and global policy uncertainty
Early signs of order inflow recovery since Oct’25
CHG:
Q3 revenue up 2% YoY to ₹668 crore
Acquisition of Kenalog® (up to US$100 million) to strengthen portfolio
PCH:
Q3 revenue up 20% YoY to ₹334 crore
Power Brands contributed 51% of segment sales
Outlook & Developments
US$90 million investment underway to expand US facilities (Lexington & Riverview)
30 regulatory inspections cleared in 9MFY26 with Zero OAI status
Management expects Q4FY26 to be the strongest quarter, with momentum continuing thereafter.
